Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1-Nrf2 signaling pathway

Bhagyalakshmi Nair1,2, Jayaprakash K Adithya1,3, Gopika Chandrababu1,2

  • 1Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

PubMed

Insights

Nutraceuticals can modulate the Keap1-Nrf2 pathway, impacting cancer development. While some compounds show promise in preclinical studies, further research is needed to confirm their effectiveness in cancer chemoprevention.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Nutritional science

Background:

  • The Keap1-Nrf2 signaling cascade plays a dual role in cancer, potentially preventing or promoting it.
  • Nutraceuticals, derived from food sources, are recognized for their health benefits and potential in cancer chemoprevention.
  • The Nrf2 pathway's complex role includes protecting normal cells but also potentially aiding tumor growth.

Purpose of the Study:

  • To systematically review the role of 12 nutraceuticals in modulating the Nrf2/Keap1 signaling pathway.
  • To assess the potential of these nutraceuticals as cancer chemoprevention agents.
  • To highlight the most studied nutraceuticals within this context.

Main Methods:

  • Systematic analysis of existing literature on nutraceuticals and the Nrf2/Keap1 pathway.
  • Identification of key nutraceuticals investigated for their modulatory effects.
  • Focus on nutraceuticals with Generally Recognized As Safe (GRAS) certification.

Main Results:

  • Twelve nutraceuticals, including curcumin, sulforaphane, and resveratrol, were analyzed for their impact on Nrf2/Keap1 signaling.
  • Sulforaphane emerged as the most extensively studied GRAS-certified compound in modulating this pathway.
  • Preclinical evidence suggests potential roles for these nutraceuticals, but clinical validation is limited.

Conclusions:

  • Nutraceuticals show potential in modulating the Keap1-Nrf2 pathway for cancer chemoprevention.
  • Sulforaphane is a prominent nutraceutical studied for its effects on Nrf2/Keap1 signaling.
  • High-quality clinical research is essential to validate the therapeutic potential of these compounds.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K